A broadly reactive ultralong bovine antibody that can determine the integrity of foot-and-mouth disease virus capsids.
Clarke JD. et al, (2024), The Journal of general virology, 105
The impact of exchanging the light and heavy chains on the structures of bovine ultralong antibodies
Clarke JD. et al, (2024), Acta Crystallographica Section F Structural Biology Communications, 80, 154 - 163
Cachd1 interacts with Wnt receptors and regulates neuronal asymmetry in the zebrafish brain
Powell GT. et al, (2024), Science, 384, 573 - 579
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nature communications, 15
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.
Ragonnet-Cronin M. et al, (2023), Nat Commun, 14
Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
Dijokaite-Guraliuc A. et al, (2022), Cell Discovery, 8
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
Huang K-YA. et al, (2022), Theranostics, 12, 1 - 17
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants.
Liu C. et al, (2022), Cell host & microbe, 30, 53 - 68.e12
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13
Antibody evasion by the P.1 strain of SARS-CoV-2
Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22
Caffeine inhibits Notum activity by binding at the catalytic pocket
Zhao Y. et al, (2020), Communications Biology, 3
Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10
Zhao Y. et al, (2020), Nature Communications, 11